Dr. Meghan Chlebowski · Utility of Serum Matrix Metalloproteinase-7 as a Biomarker in Cholestatic Infants with Congenital Heart Disease
Follow
Article1 min read·Published Oct 2024Older

Utility of Serum Matrix Metalloproteinase-7 as a Biomarker in Cholestatic Infants with Congenital Heart Disease

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Oct 2024 · 1 min read

In brief

In brief

This study evaluates MMP-7 as a diagnostic biomarker for biliary atresia in cholestatic infants with congenital heart disease, finding significantly elevated levels in CHD patients, particularly those with pulmonary hypertension. The findings suggest MMP-7's utility may be limited in this population due to confounding cardiac factors.

Written by the GCMD Library team from the article.

Dr. Meghan Chlebowski

This study evaluates MMP-7 as a diagnostic biomarker for biliary atresia in cholestatic infants with congenital heart disease, finding significantly elevated levels in CHD patients, particularly those with pulmonary hypertension. The findings suggest MMP-7's utility may be limited in this population due to confounding cardiac factors.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
Only a few other public items share this field — go deeper there →